Showing results (211-220 of 301) with videos related to
Sort By:
Pageof 31
Cancer Biotherapy & Radiopharmaceuticals|September 17, 2014
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled PeptideCatharina M van Rij, Cathelijne Frielink, David M Goldenberg, et al.Contrast Media & Molecular Imaging|April 23, 2013
Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptideIngrid Dijkgraaf, Samantha Y A Terry, William J McBride, et al.Molecular Cancer Therapeutics|December 14, 2002
Molecular advances in pretargeting radioimunotherapy with bispecific antibodiesChien-Hsing Chang, Robert M Sharkey, Edmund A Rossi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumabOla Lindén, Cecilia Hindorf, Eva Cavallin-Ståhl, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
A novel method of 18F radiolabeling for PETWilliam J McBride, Robert M Sharkey, Habibe Karacay, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2007
IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survivalInbal Binsky, Michal Haran, Diana Starlets, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2010
TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent mannerInbal Binsky, Frida Lantner, Valentin Grabovsky, et al.Breast Cancer Research and Treatment|March 5, 2004
Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabelSerengulam V Govindan, Rhona Stein, Zhengxing Qu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodiesPierre-Yves Brard, Habibe Karacay, Rhona Stein, et al.Cancer Research|January 9, 2003
Improved iodine radiolabels for monoclonal antibody therapyRhona Stein, Serengulam V Govindan, M Jules Mattes, et al.Pageof 31